A Dark Vector Cognition product

Item 4. Controls and Procedures.

4K characters. Original on sec.gov ·

Item 4. Controls and Procedures.

Controls and Procedures.

We,

under the

supervision and

with the

participation of

our management,

including our

Chief Executive

Officer and

Chief Financial

Officer,

have

evaluated

the

effectiveness

of

the design

and

operation

of

our

disclosure

controls

and

procedures

(as

defined

in

Rule

13a-15(e)

under

the

Securities

Exchange

Act

of

1934).

Based

on

our

evaluation,

our

Chief

Executive

Officer

and

Chief

Financial

Officer have

concluded that,

as of

August 24,

2025, our

disclosure controls

and procedures

were effective

to ensure

that information

required to

be disclosed

by us

in reports

that we file

or submit

under the

Securities Exchange

Act of

1934 is (1)

recorded, processed,

summarized,

and

reported

within

the

time

periods

specified

in

Securities

and

Exchange

Commission

rules

and

forms,

and

(2)

accumulated and

communicated to

our management,

including our

Chief Executive

Officer and

Chief Financial

Officer,

in a

manner

that allows timely decisions regarding required disclosure.

There were no changes in our internal

control over financial reporting (as defined

in Rule 13a-15(f) under the Securities Exchange

Act

of 1934)

during the

quarter ended

August 24,

2025, that

materially affected,

or are reasonably

likely to

materially affect,

our internal

control over financial reporting.

PART

II.

OTHER INFORMATION

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

The

following

table

sets forth

information

with

respect

to

shares

of

our

common

stock

that we

purchased

during

the quarter

ended

August 24, 2025:

Period

Total

Number

of Shares

Purchased (a)

Average

Price Paid

Per Share (b)

Total

Number of Shares

Purchased as Part of a Publicly

Announced Program (c)

Maximum Number of Shares

that may yet be Purchased

Under the Program (c)

May 26, 2025 -

June 29, 2025

-

$

-

-

36,918,163

June 30, 2025 -

July 27, 2025 (d)

7,520,212

49.92

7,520,212

29,397,951

July 28, 2025 -

August 24, 2025 (d)

1,199,631

50.41

1,199,631

28,198,320

Total

8,719,843

$

49.99

8,719,843

28,198,320

(a)

The total number

of shares purchased

includes shares of

common stock withheld

for the payment

of withholding taxes

upon the distribution

of

deferred option units.

(b)

Excludes commissions paid and other costs of execution, including excise taxes.

(c)

On June

27, 2022,

our Board

of Directors approved

an authorization

for the

repurchase of

up to

100,000,000 shares of

our common stock

and

terminated the

prior authorization.

Purchases can

be made

in the

open market

or in

privately negotiated

transactions, including

the use

of call

options

and

other

derivative

instruments,

Rule

10b5-1

trading

plans,

and

accelerated

repurchase

programs.

The

Board

did

not

specify

an

expiration date for the authorization.

(d)

In the

first quarter

of fiscal

2026, we

entered into

two accelerated

share repurchase

(ASR) agreements

with an

unrelated third-party

financial

institution to repurchase an aggregate of $500.0 million of our

shares. We paid

an aggregate of $500.0 million and received an initial delivery of

7.5 million

shares of

our common stock

based on

the closing

share price of

our common

stock on July

1, 2025.

The value

of the

initial shares

delivered under the

ASR agreements represented 80

percent of the

aggregate purchase price,

with a fair value

of $400.0 million.

The first ASR

agreement was

settled on

August 4,

2025, with

a final

delivery of

1.2 million

additional shares.

The final

average purchase

price for

the first

ASR

agreement

was

$50.41

per

share,

not

including

costs

of

execution

or

excise

tax.

The

final

settlement

of

the

second

ASR

agreement

occurred on August

29, 2025, during

the second quarter

of fiscal 2026,

with a final

delivery of 1.3

million additional shares.

The final average

purchase price for the second ASR agreement was $49.45 per share, not including costs of execution or excise tax.

Previous: Item 3. Quantitative and Qualitative Disclosures About Market Risk. · Next: Item 5. Other Information.